Kellner M, Hörmann J, Fackler S, Hu Y, Zhou T, Lu L, Ilik I, Aktas T, Feederle R, Hauck SM, Gires O, Gärtner K, Li L, Zeidler R (2024)
The Nuclear Speckles Protein SRRM2 Is Exposed on the Surface of Cancer Cells.
Cells, Issue 18, Vol. 13
DOI: 10.3390/cells13181563, PubMed: 39329747 |
Kohantorabi M, Ugolotti A, Sochor B, Roessler J, Wagstaffe M, Meinhardt A, Beck EE, Dolling DS, Garcia MB, Creutzburg M, Keller TF, Schwartzkopf M, Vayalil SK, Thuenauer R, Guédez G, Löw C, Ebert G, Protzer U, Hammerschmidt W, Zeidler R, Roth SV, Di Valentin C, Stierle A, Noei H (2024)
Light-Induced Transformation of Virus-Like Particles on TiO2.
ACS applied materials & interfaces, Issue 28, Vol. 16, 37275-37287
DOI: 10.1021/acsami.4c07151, PubMed: 38959130 |
Theobald SJ, Fiestas E, Schneider A, Ostermann B, Danisch S, von Kaisenberg C, Rybniker J, Hammerschmidt W, Zeidler R, Stripecke R (2023)
Fully Human Herpesvirus-Specific Neutralizing IgG Antibodies Generated by EBV Immortalization of Splenocytes-Derived from Immunized Humanized Mice.
Cells, Issue 1, Vol. 13
DOI: 10.3390/cells13010020, PubMed: 38201224 |
Roessler J, Pich D, Krähling V, Becker S, Keppler OT, Zeidler R, Hammerschmidt W (2023)
SARS-CoV-2 and Epstein-Barr Virus-like Particles Associate and Fuse with Extracellular Vesicles in Virus Neutralization Tests.
Biomedicines, Issue 11, Vol. 11
DOI: 10.3390/biomedicines11112892, PubMed: 38001893 |
Roll W, Müther M, Böning G, Delker A, Warneke N, Gildehaus FJ, Schäfers M, Stummer W, Zeidler R, Reulen HJ, Stegger L (2023)
First clinical experience with fractionated intracavitary radioimmunotherapy using [177Lu]Lu-6A10-Fab fragments in patients with glioblastoma: a pilot study.
EJNMMI research, Issue 1, Vol. 13, 78
DOI: 10.1186/s13550-023-01029-7, PubMed: 37665396 |
Shi E, Wu Z, Karaoglan BS, Schwenk-Zieger S, Kranz G, Abdul Razak N, Reichel CA, Canis M, Baumeister P, Zeidler R, Gires O (2023)
5'-Ectonucleotidase CD73/NT5E supports EGFR-mediated invasion of HPV-negative head and neck carcinoma cells.
Journal of biomedical science, Issue 1, Vol. 30, 72
DOI: 10.1186/s12929-023-00968-6, PubMed: 37620936 |
Roessler J, Pich D, Albanese M, Wratil PR, Krähling V, Hellmuth JC, Scherer C, von Bergwelt-Baildon M, Becker S, Keppler OT, Brisson A, Zeidler R, Hammerschmidt W (2022)
Quantitation of SARS-CoV-2 neutralizing antibodies with a virus-free, authentic test.
PNAS nexus, Issue 2, Vol. 1
DOI: 10.1093/pnasnexus/pgac045, PubMed: 36382127 |
Hiepp L, Mayr D, Gärtner K, Schmoeckel E, Klauschen F, Burges A, Mahner S, Zeidler R, Czogalla B (2022)
Carbonic anhydrase XII as biomarker and therapeutic target in ovarian carcinomas.
PloS one, Issue 7, Vol. 17, e0271630
DOI: 10.1371/journal.pone.0271630, PubMed: 35901081 |
Kellner M, von Neubeck B, Czogalla B, Feederle R, Vick B, Jeremias I, Zeidler R (2022)
A Novel Anti-CD73 Antibody That Selectively Inhibits Membrane CD73 Shows Antitumor Activity and Induces Tumor Immune Escape.
Biomedicines, Issue 4, Vol. 10
DOI: 10.3390/biomedicines10040825, PubMed: 35453575 |
Kogan PS, Wirth F, Tomar A, Darr J, Teperino R, Lahm H, Dreßen M, Puluca N, Zhang Z, Neb I, Beck N, Luzius T, de la Osa de la Rosa L, Gärtner K, Hüls C, Zeidler R, Ramanujam D, Engelhardt S, Wenk C, Holdt LM, Mononen M, Sahara M, Cleuziou J, Hörer J, Lange R, Krane M, Doppler SA (2022)
Uncovering the molecular identity of cardiosphere-derived cells (CDCs) by single-cell RNA sequencing.
Basic research in cardiology, Issue 1, Vol. 117, 11
DOI: 10.1007/s00395-022-00913-y, PubMed: 35258704 |
Testa C, Papini AM, Zeidler R, Vullo D, Carta F, Supuran CT, Rovero P (2022)
First studies on tumor associated carbonic anhydrases IX and XII monoclonal antibodies conjugated to small molecule inhibitors.
Journal of enzyme inhibition and medicinal chemistry, Issue 1, Vol. 37, 592-596
DOI: 10.1080/14756366.2021.2004593, PubMed: 35057692 |
Albanese M, Chen YA, Hüls C, Gärtner K, Tagawa T, Mejias-Perez E, Keppler OT, Göbel C, Zeidler R, Shein M, Schütz AK, Hammerschmidt W (2021)
MicroRNAs are minor constituents of extracellular vesicles that are rarely delivered to target cells.
PLoS genetics, Issue 12, Vol. 17, e1009951
DOI: 10.1371/journal.pgen.1009951, PubMed: 34871319 |
Li G, Chen TW, Nickel AC, Muhammad S, Steiger HJ, Tzaridis T, Hänggi D, Zeidler R, Zhang W, Kahlert UD (2021)
Carbonic Anhydrase XII is a Clinically Significant, Molecular Tumor-Subtype Specific Therapeutic Target in Glioma with the Potential to Combat Invasion of Brain Tumor Cells.
OncoTargets and therapy, Vol. 14, 1707-1718
DOI: 10.2147/OTT.S300623, PubMed: 33692626 |
Slabik C, Kalbarczyk M, Danisch S, Zeidler R, Klawonn F, Volk V, Krönke N, Feuerhake F, Ferreira de Figueiredo C, Blasczyk R, Olbrich H, Theobald SJ, Schneider A, Ganser A, von Kaisenberg C, Lienenklaus S, Bleich A, Hammerschmidt W, Stripecke R (2020)
CAR-T Cells Targeting Epstein-Barr Virus gp350 Validated in a Humanized Mouse Model of EBV Infection and Lymphoproliferative Disease.
Molecular therapy oncolytics, Vol. 18, 504-524
DOI: 10.1016/j.omto.2020.08.005, PubMed: 32953984 |
Kühne JF, Neudörfl C, Beushausen K, Keil J, Malysheva S, Wandrer F, Haller H, Messerle M, Blume C, Neuenhahn M, Schlott F, Hammerschmidt W, Zeidler R, Falk CS (2020)
Differential effects of Belatacept on virus-specific memory versus de novo allo-specific T cell responses of kidney transplant recipients and healthy donors.
Transplant immunology, Vol. 61, 101291
DOI: 10.1016/j.trim.2020.101291, PubMed: 32330566 |
Pan C, Schoppe O, Parra-Damas A, Cai R, Todorov MI, Gondi G, von Neubeck B, Böğürcü-Seidel N, Seidel S, Sleiman K, Veltkamp C, Förstera B, Mai H, Rong Z, Trompak O, Ghasemigharagoz A, Reimer MA, Cuesta AM, Coronel J, Jeremias I, Saur D, Acker-Palmer A, Acker T, Garvalov BK, Menze B, Zeidler R, Ertürk A (2019)
Deep Learning Reveals Cancer Metastasis and Therapeutic Antibody Targeting in the Entire Body.
Cell, Issue 7, Vol. 179, 1661-1676.e19
DOI: 10.1016/j.cell.2019.11.013, PubMed: 31835038 |
Alterio V, Kellner M, Esposito D, Liesche-Starnecker F, Bua S, Supuran CT, Monti SM, Zeidler R, De Simone G (2019)
Biochemical and Structural Insights into Carbonic Anhydrase XII/Fab6A10 Complex.
Journal of molecular biology, Issue 24, Vol. 431, 4910-4921
DOI: 10.1016/j.jmb.2019.10.022, PubMed: 31682835 |
Hofmann T, Schmitt B, Mack B, Lang S, Gires O, Zeidler R (2004)
New Target Genes for Tumor-derived Soluble Factors in Primary Monocytes.
Cancer genomics & proteomics, Issue 2, Vol. 1, 167-176
PubMed: 31394681 |
Münz M, Hofmann T, Scheibe B, Gänge M, Junghanns KT, Zeidler R, Gires O (2004)
The Carcinoma-associated Antigen EpCAM Induces Glyoxalase 1 Resulting in Enhanced Methylglyoxal Turnover.
Cancer genomics & proteomics, Issue 3, Vol. 1, 241-248
PubMed: 31394659 |
Reulen HJ, Suero Molina E, Zeidler R, Gildehaus FJ, Böning G, Gosewisch A, Stummer W (2019)
Intracavitary radioimmunotherapy of high-grade gliomas: present status and future developments.
Acta neurochirurgica, Issue 6, Vol. 161, 1109-1124
DOI: 10.1007/s00701-019-03882-9, PubMed: 30980242 |
Gärtner K, Luckner M, Wanner G, Zeidler R (2019)
Engineering extracellular vesicles as novel treatment options: exploiting herpesviral immunity in CLL.
Journal of extracellular vesicles, Issue 1, Vol. 8, 1573051
DOI: 10.1080/20013078.2019.1573051, PubMed: 30788083 |
Danisch S, Slabik C, Cornelius A, Albanese M, Tagawa T, Chen YA, Krönke N, Eiz-Vesper B, Lienenklaus S, Bleich A, Theobald SJ, Schneider A, Ganser A, von Kaisenberg C, Zeidler R, Hammerschmidt W, Feuerhake F, Stripecke R (2019)
Spatiotemporally Skewed Activation of Programmed Cell Death Receptor 1-Positive T Cells after Epstein-Barr Virus Infection and Tumor Development in Long-Term Fully Humanized Mice.
The American journal of pathology, Issue 3, Vol. 189, 521-539
DOI: 10.1016/j.ajpath.2018.11.014, PubMed: 30593822 |
Kazokaitė J, Niemans R, Dudutienė V, Becker HM, Leitāns J, Zubrienė A, Baranauskienė L, Gondi G, Zeidler R, Matulienė J, Tārs K, Yaromina A, Lambin P, Dubois LJ, Matulis D (2018)
Novel fluorinated carbonic anhydrase IX inhibitors reduce hypoxia-induced acidification and clonogenic survival of cancer cells.
Oncotarget, Issue 42, Vol. 9, 26800-26816
DOI: 10.18632/oncotarget.25508, PubMed: 29928486 |
von Neubeck B, Gondi G, Riganti C, Pan C, Parra Damas A, Scherb H, Ertürk A, Zeidler R (2018)
An inhibitory antibody targeting carbonic anhydrase XII abrogates chemoresistance and significantly reduces lung metastases in an orthotopic breast cancer model in vivo.
International journal of cancer, Issue 8, Vol. 143, 2065-2075
DOI: 10.1002/ijc.31607, PubMed: 29786141 |
Fiedler L, Kellner M, Oos R, Böning G, Ziegler S, Bartenstein P, Zeidler R, Gildehaus FJ, Lindner S (2018)
Fully Automated Production and Characterization of 64 Cu and Proof-of-Principle Small-Animal PET Imaging Using 64 Cu-Labelled CA XII Targeting 6A10 Fab.
ChemMedChem, Issue 12, Vol. 13, 1230-1237
DOI: 10.1002/cmdc.201800130, PubMed: 29667369 |
Gärtner K, Battke C, Dünzkofer J, Hüls C, von Neubeck B, Kellner MK, Fiestas E, Fackler S, Lang S, Zeidler R (2018)
Tumor-derived extracellular vesicles activate primary monocytes.
Cancer medicine, Issue 5, Vol. 7, 2013-2020
DOI: 10.1002/cam4.1465, PubMed: 29601673 |
Rancan C, Schirrmann L, Hüls C, Zeidler R, Moosmann A (2015)
Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells by CD8+ T Cells.
PLoS pathogens, Issue 6, Vol. 11, e1004906
DOI: 10.1371/journal.ppat.1004906, PubMed: 26067064 |
Uda NR, Seibert V, Stenner-Liewen F, Müller P, Herzig P, Gondi G, Zeidler R, van Dijk M, Zippelius A, Renner C (2015)
Esterase activity of carbonic anhydrases serves as surrogate for selecting antibodies blocking hydratase activity.
Journal of enzyme inhibition and medicinal chemistry, Issue 6, Vol. 30, 955-60
DOI: 10.3109/14756366.2014.1001754, PubMed: 25775095 |
Kim DK, Lee J, Kim SR, Choi DS, Yoon YJ, Kim JH, Go G, Nhung D, Hong K, Jang SC, Kim SH, Park KS, Kim OY, Park HT, Seo JH, Aikawa E, Baj-Krzyworzeka M, van Balkom BW, Belting M, Blanc L, Bond V, Bongiovanni A, Borràs FE, Buée L, Buzás EI, Cheng L, Clayton A, Cocucci E, Dela Cruz CS, Desiderio DM, Di Vizio D, Ekström K, Falcon-Perez JM, Gardiner C, Giebel B, Greening DW, Gross JC, Gupta D, Hendrix A, Hill AF, Hill MM, Nolte-'t Hoen E, Hwang DW, Inal J, Jagannadham MV, Jayachandran M, Jee YK, Jørgensen M, Kim KP, Kim YK, Kislinger T, Lässer C, Lee DS, Lee H, van Leeuwen J, Lener T, Liu ML, Lötvall J, Marcilla A, Mathivanan S, Möller A, Morhayim J, Mullier F, Nazarenko I, Nieuwland R, Nunes DN, Pang K, Park J, Patel T, Pocsfalvi G, Del Portillo H, Putz U, Ramirez MI, Rodrigues ML, Roh TY, Royo F, Sahoo S, Schiffelers R, Sharma S, Siljander P, Simpson RJ, Soekmadji C, Stahl P, Stensballe A, Stępień E, Tahara H, Trummer A, Valadi H, Vella LJ, Wai SN, Witwer K, Yáñez-Mó M, Youn H, Zeidler R, Gho YS (2015)
EVpedia: a community web portal for extracellular vesicles research.
Bioinformatics (Oxford, England), Issue 6, Vol. 31, 933-9
DOI: 10.1093/bioinformatics/btu741, PubMed: 25388151 |
Weller P, Bankfalvi A, Gu X, Dominas N, Lehnerdt GF, Zeidler R, Lang S, Brandau S, Dumitru CA (2014)
The role of tumour FoxP3 as prognostic marker in different subtypes of head and neck cancer.
European journal of cancer (Oxford, England : 1990), Issue 7, Vol. 50, 1291-300
DOI: 10.1016/j.ejca.2014.02.016, PubMed: 24630394 |
Gondi G, Mysliwietz J, Hulikova A, Jen JP, Swietach P, Kremmer E, Zeidler R (2013)
Antitumor efficacy of a monoclonal antibody that inhibits the activity of cancer-associated carbonic anhydrase XII.
Cancer research, Issue 21, Vol. 73, 6494-503
DOI: 10.1158/0008-5472.CAN-13-1110, PubMed: 24030978 |
Dumitru CA, Bankfalvi A, Gu X, Eberhardt WE, Zeidler R, Lang S, Brandau S (2013)
Neutrophils Activate Tumoral CORTACTIN to Enhance Progression of Orohypopharynx Carcinoma.
Frontiers in immunology, Vol. 4, 33
DOI: 10.3389/fimmu.2013.00033, PubMed: 23423155 |
Dumitru CA, Bankfalvi A, Gu X, Zeidler R, Brandau S, Lang S (2013)
AHNAK and inflammatory markers predict poor survival in laryngeal carcinoma.
PloS one, Issue 2, Vol. 8, e56420
DOI: 10.1371/journal.pone.0056420, PubMed: 23409183 |
Lee JH, Wittki S, Bräu T, Dreyer FS, Krätzel K, Dindorf J, Johnston IC, Gross S, Kremmer E, Zeidler R, Schlötzer-Schrehardt U, Lichtenheld M, Saksela K, Harrer T, Schuler G, Federico M, Baur AS (2013)
HIV Nef, paxillin, and Pak1/2 regulate activation and secretion of TACE/ADAM10 proteases.
Molecular cell, Issue 4, Vol. 49, 668-79
DOI: 10.1016/j.molcel.2012.12.004, PubMed: 23317503 |
Ruiss R, Ohno S, Steer B, Zeidler R, Adler H (2012)
Murine gammaherpesvirus 68 glycoprotein 150 does not contribute to latency amplification in vivo.
Virology journal, Vol. 9, 107
DOI: 10.1186/1743-422X-9-107, PubMed: 22681851 |
Jochum S, Moosmann A, Lang S, Hammerschmidt W, Zeidler R (2012)
The EBV immunoevasins vIL-10 and BNLF2a protect newly infected B cells from immune recognition and elimination.
PLoS pathogens, Issue 5, Vol. 8, e1002704
DOI: 10.1371/journal.ppat.1002704, PubMed: 22615564 |
Jochum S, Ruiss R, Moosmann A, Hammerschmidt W, Zeidler R (2012)
RNAs in Epstein-Barr virions control early steps of infection.
Proceedings of the National Academy of Sciences of the United States of America, Issue 21, Vol. 109, E1396-404
DOI: 10.1073/pnas.1115906109, PubMed: 22543160 |
Ruiss R, Jochum S, Mocikat R, Hammerschmidt W, Zeidler R (2011)
EBV-gp350 confers B-cell tropism to tailored exosomes and is a neo-antigen in normal and malignant B cells--a new option for the treatment of B-CLL.
PloS one, Issue 10, Vol. 6, e25294
DOI: 10.1371/journal.pone.0025294, PubMed: 22022385 |
Ruiss R, Jochum S, Wanner G, Reisbach G, Hammerschmidt W, Zeidler R (2011)
A virus-like particle-based Epstein-Barr virus vaccine.
Journal of virology, Issue 24, Vol. 85, 13105-13
DOI: 10.1128/JVI.05598-11, PubMed: 21994444 |
Andratschke M, Luebbers CW, Johannson V, Schmitt B, Mack B, Zeidler R, Lang S, Wollenberg B, Gildehaus FJ (2011)
Biodistribution of 131I-labeled anti-CK8 monoclonal antibody in HNSCC in xenotransplanted SCID mice.
Anticancer research, Issue 10, Vol. 31, 3315-21
PubMed: 21965741 |
Battke C, Kremmer E, Mysliwietz J, Gondi G, Dumitru C, Brandau S, Lang S, Vullo D, Supuran C, Zeidler R (2011)
Generation and characterization of the first inhibitory antibody targeting tumour-associated carbonic anhydrase XII.
Cancer immunology, immunotherapy : CII, Issue 5, Vol. 60, 649-58
DOI: 10.1007/s00262-011-0980-z, PubMed: 21298264 |
Battke C, Ruiss R, Welsch U, Wimberger P, Lang S, Jochum S, Zeidler R (2011)
Tumour exosomes inhibit binding of tumour-reactive antibodies to tumour cells and reduce ADCC.
Cancer immunology, immunotherapy : CII, Issue 5, Vol. 60, 639-48
DOI: 10.1007/s00262-011-0979-5, PubMed: 21293856 |
Bergmann C, Strauss L, Wieckowski E, Czystowska M, Albers A, Wang Y, Zeidler R, Lang S, Whiteside TL (2009)
Tumor-derived microvesicles in sera of patients with head and neck cancer and their role in tumor progression.
Head & neck, Issue 3, Vol. 31, 371-80
DOI: 10.1002/hed.20968, PubMed: 19073006 |
Wiesner M, Zentz C, Mayr C, Wimmer R, Hammerschmidt W, Zeidler R, Moosmann A (2008)
Conditional immortalization of human B cells by CD40 ligation.
PloS one, Issue 1, Vol. 3, e1464
DOI: 10.1371/journal.pone.0001464, PubMed: 18213373 |
Albermann K, Lang S, Zeidler R (2007)
Molecular profiling for the identification of new biomarkers in smokers and cancer patients.
Cancer genomics & proteomics, Issue 5, Vol. 4, 349-58
PubMed: 17993719 |
Bergmann C, Strauss L, Zeidler R, Lang S, Whiteside TL (2007)
Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma.
Cancer research, Issue 18, Vol. 67, 8865-73
DOI: 10.1158/0008-5472.CAN-07-0767, PubMed: 17875728 |
Zeidler R, Albermann K, Lang S (2007)
Nicotine and apoptosis.
Apoptosis : an international journal on programmed cell death, Issue 11, Vol. 12, 1927-43
DOI: 10.1007/s10495-007-0102-8, PubMed: 17846896 |
Lang S, Tiwari S, Andratschke M, Loehr I, Lauffer L, Bergmann C, Mack B, Lebeau A, Moosmann A, Whiteside TL, Zeidler R (2007)
Immune restoration in head and neck cancer patients after in vivo COX-2 inhibition.
Cancer immunology, immunotherapy : CII, Issue 10, Vol. 56, 1645-52
DOI: 10.1007/s00262-007-0312-5, PubMed: 17387473 |
Andratschke M, Gildehaus FJ, Johannson V, Schmitt B, Mack B, Reisbach G, Lang S, Lindhofer H, Zeidler R, Wollenberg B, Luebbers CW (2007)
Biodistribution and radioimmunotherapy of SCCHN in xenotransplantated SCID mice with a 131I-labelled anti-EpCAM monoclonal antibody.
Anticancer research, Issue 1A, Vol. 27, 431-6
PubMed: 17352264 |
Zentz C, Wiesner M, Man S, Frankenberger B, Wollenberg B, Hillemanns P, Zeidler R, Hammerschmidt W, Moosmann A (2007)
Activated B cells mediate efficient expansion of rare antigen-specific T cells.
Human immunology, Issue 2, Vol. 68, 75-85
DOI: 10.1016/j.humimm.2006.12.004, PubMed: 17321896 |
Bergmann C, Strauss L, Zeidler R, Lang S, Whiteside TL (2007)
Expansion and characteristics of human T regulatory type 1 cells in co-cultures simulating tumor microenvironment.
Cancer immunology, immunotherapy : CII, Issue 9, Vol. 56, 1429-42
DOI: 10.1007/s00262-007-0280-9, PubMed: 17265021 |
Ahlemann M, Zeidler R, Lang S, Mack B, Münz M, Gires O (2006)
Carcinoma-associated eIF3i overexpression facilitates mTOR-dependent growth transformation.
Molecular carcinogenesis, Issue 12, Vol. 45, 957-67
DOI: 10.1002/mc.20269, PubMed: 16929481 |
Ahlemann M, Schmitt B, Stieber P, Gires O, Lang S, Zeidler R (2006)
Evaluation of CK8-specific autoantibodies in carcinomas of distinct localisations.
Anticancer research, Issue 1B, Vol. 26, 783-9
PubMed: 16739354 |
Andratschke M, Hagedorn H, Luebbers CW, Schmitt B, Lang S, Zeidler R, Wollenberg B (2006)
Limited suitability of EpCAM for molecular staging of tumor borders in head and neck cancer.
Anticancer research, Issue 1A, Vol. 26, 153-8
PubMed: 16475692 |
Walz A, Andratschke M, Wollenberg B, Lindhofer H, Zeidler R (2005)
Prednisolone reduces TNF-alpha release by PBMCs activated with a trifunctional bispecific antibody but not their anti-tumor activity.
Anticancer research, Issue 6B, Vol. 25, 4239-43
PubMed: 16309222 |
Wiesner M, Zentz C, Hammer MH, Cobbold M, Kern F, Kolb HJ, Hammerschmidt W, Zeidler R, Moosmann A (2005)
Selection of CMV-specific CD8+ and CD4+ T cells by mini-EBV-transformed B cell lines.
European journal of immunology, Issue 7, Vol. 35, 2110-21
DOI: 10.1002/eji.200425936, PubMed: 15971271 |
Münz M, Zeidler R, Gires O (2005)
The tumour-associated antigen EpCAM upregulates the fatty acid binding protein E-FABP.
Cancer letters, Issue 1, Vol. 225, 151-7
DOI: 10.1016/j.canlet.2004.11.048, PubMed: 15922867 |
Rauch J, Ahlemann M, Schaffrik M, Mack B, Ertongur S, Andratschke M, Zeidler R, Lang S, Gires O (2004)
Allogenic antibody-mediated identification of head and neck cancer antigens.
Biochemical and biophysical research communications, Issue 1, Vol. 323, 156-62
DOI: 10.1016/j.bbrc.2004.08.071, PubMed: 15351715 |
Münz M, Kieu C, Mack B, Schmitt B, Zeidler R, Gires O (2004)
The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation.
Oncogene, Issue 34, Vol. 23, 5748-58
DOI: 10.1038/sj.onc.1207610, PubMed: 15195135 |
Walz A, Mack B, Schmitt B, Gires O, Wollenberg B, Zeidler R (2004)
Antitumour effects of a bispecific trivalent antibody in multicellular tumour spheroids.
Anticancer research, Issue 2B, Vol. 24, 887-93
PubMed: 15161042 |
Schlee M, Krug T, Gires O, Zeidler R, Hammerschmidt W, Mailhammer R, Laux G, Sauer G, Lovric J, Bornkamm GW (2004)
Identification of Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) target proteins by proteome analysis: activation of EBNA2 in conditionally immortalized B cells reflects early events after infection of primary B cells by EBV.
Journal of virology, Issue 8, Vol. 78, 3941-52
DOI: 10.1128/jvi.78.8.3941-3952.2004, PubMed: 15047810 |
Gires O, Eskofier S, Lang S, Zeidler R, Münz M (2003)
Cloning and characterisation of a 1.1 kb fragment of the carcinoma-associated epithelial cell adhesion molecule promoter.
Anticancer research, Issue 4, Vol. 23, 3255-61
PubMed: 12926061 |
Pauli C, Münz M, Kieu C, Mack B, Breinl P, Wollenberg B, Lang S, Zeidler R, Gires O (2003)
Tumor-specific glycosylation of the carcinoma-associated epithelial cell adhesion molecule EpCAM in head and neck carcinomas.
Cancer letters, Issue 1, Vol. 193, 25-32
DOI: 10.1016/s0304-3835(03)00003-x, PubMed: 12691820 |
Lang S, Lauffer L, Clausen C, Löhr I, Schmitt B, Hölzel D, Wollenberg B, Gires O, Kastenbauer E, Zeidler R (2003)
Impaired monocyte function in cancer patients: restoration with a cyclooxygenase-2 inhibitor.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Issue 2, Vol. 17, 286-8
DOI: 10.1096/fj.02-0417fje, PubMed: 12490541 |
Moosmann A, Khan N, Cobbold M, Zentz C, Delecluse HJ, Hollweck G, Hislop AD, Blake NW, Croom-Carter D, Wollenberg B, Moss PA, Zeidler R, Rickinson AB, Hammerschmidt W (2002)
B cells immortalized by a mini-Epstein-Barr virus encoding a foreign antigen efficiently reactivate specific cytotoxic T cells.
Blood, Issue 5, Vol. 100, 1755-64
PubMed: 12176897 |
